Drug search by name

Asparaginase Erwinia chrysanthemi and Pancreatitis

Result of checking the interaction of drug Asparaginase Erwinia chrysanthemi and disease Pancreatitis for safety when used together.

Check result:

Asparaginase Erwinia chrysanthemi <> Pancreatitis

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of asparaginase Erwinia chrysanthemi is contraindicated in patients with a history of serious pancreatitis with prior L-asparaginase therapy. It is recommended to evaluate patients with symptoms compatible with pancreatitis to establish a diagnosis. In the case of mild pancreatitis, it is recommended to hold treatment until the signs and symptoms subside, and amylase levels return to normal. Discontinue treatment with this agent for severe or hemorrhagic pancreatitis manifested by abdominal pain >72 hours and amylase elevation of >= 2.0 x ULN.

Asparaginase Erwinia chrysanthemi

Generic Name: asparaginase erwinia chrysanthemi

Brand Name: Erwinaze

Synonyms: Asparaginase (Erwinia)

What is Asparaginase Erwinia chrysanthemi?